Literature DB >> 19325142

Overexpression of human 15(S)-lipoxygenase-1 in RAW macrophages leads to increased cholesterol mobilization and reverse cholesterol transport.

Ginny L Weibel1, Michelle R Joshi, Eric T Alexander, Peijuan Zhu, Ian A Blair, George H Rothblat.   

Abstract

OBJECTIVE: The purpose of this study was to determine the effect of 15-lipoxygenase-1 (15-LO-1) on cholesterol mobilization from macrophages. METHODS AND
RESULTS: Overexpression of human 15-LO-1 in RAW mouse macrophages led to enhanced cholesterol efflux, increased cholesteryl ester (CE) hydrolysis, and increased reverse cholesterol transport (RCT). Efflux studies comparing 15-LO-1 overexpressing cells to mock-transfected RAW macrophages resulted in a 3- to 7-fold increase in cholesterol efflux to apolipoprotein A-I and a modest increase in efflux to HDL. Additional experiments revealed an increase in mRNA and protein levels of ABCA1 and ABCG1 in the RAW expressing 15-LO-1 compared to controls. Efforts to examine whether the arachidonic acid metabolite of 15-LO-1, (15S)-hydroxyeicosatetraenoic acid (HETE), was responsible for the enhanced efflux revealed this eicosanoid metabolite did not play a role. Enhanced steryl ester hydrolysis was observed in 15-LO-1 overexpressing cells suggesting that the CE produced in the 15-LO-1 expressing cells was readily mobilized. To measure RCT, RAW macrophages overexpressing 15-LO-1 or mock-transfected cells were cholesterol enriched by exposure to acetylated low-density lipoprotein and [(3)H]-cholesterol. These macrophages were injected into wild-type animals and RCT was measured as a percent of injected dose of (3)H appearing in the feces at 48 hours. We found 7% of the injected (3)H in the feces of mice that received macrophages overexpressing 15-LO-1 and 4% in the feces of mice that received mock-transfected cells.
CONCLUSIONS: These data are consistent with a model in which overexpression of human 15-LO-1 in RAW macrophages promotes RCT through increased CE hydrolysis and ABCA1-mediated cholesterol efflux.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19325142      PMCID: PMC2759530          DOI: 10.1161/ATVBAHA.109.186163

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  38 in total

1.  George Lyman Duff memorial lecture. Progression and regression of atherosclerotic lesions. Insights from lipid physical biochemistry.

Authors:  D M Small
Journal:  Arteriosclerosis       Date:  1988 Mar-Apr

2.  Human white/murine ABC8 mRNA levels are highly induced in lipid-loaded macrophages. A transcriptional role for specific oxysterols.

Authors:  A Venkateswaran; J J Repa; J M Lobaccaro; A Bronson; D J Mangelsdorf; P A Edwards
Journal:  J Biol Chem       Date:  2000-05-12       Impact factor: 5.157

3.  Gene expression in macrophage-rich human atherosclerotic lesions. 15-lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts.

Authors:  S Ylä-Herttuala; M E Rosenfeld; S Parthasarathy; E Sigal; T Särkioja; J L Witztum; D Steinberg
Journal:  J Clin Invest       Date:  1991-04       Impact factor: 14.808

4.  Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.

Authors:  T Cyrus; D Praticò; L Zhao; J L Witztum; D J Rader; J Rokach; G A FitzGerald; C D Funk
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

5.  Anti-inflammatory drugs in experimental atherosclerosis. 7. Spontaneous atherosclerosis in WHHL rabbits and inhibition by cortisone acetate.

Authors:  A N Makheja; S Bloom; R Muesing; T Simon; J M Bailey
Journal:  Atherosclerosis       Date:  1989-04       Impact factor: 5.162

6.  High-density-lipoprotein-induced cholesterol efflux from arterial smooth muscle cell derived foam cells: functional relationship of the cholesteryl ester cycle and eicosanoid biosynthesis.

Authors:  K B Pomerantz; D P Hajjar
Journal:  Biochemistry       Date:  1990-02-20       Impact factor: 3.162

7.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis.

Authors:  Rainer Spanbroek; Rolf Grabner; Katharina Lotzer; Markus Hildner; Anja Urbach; Katharina Ruhling; Michael P W Moos; Brigitte Kaiser; Tina U Cohnert; Thorsten Wahlers; Arthur Zieske; Gabriele Plenz; Horst Robenek; Peter Salbach; Hartmut Kuhn; Olof Radmark; Bengt Samuelsson; Andreas J R Habenicht
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-27       Impact factor: 11.205

8.  LXR-mediated activation of macrophage stearoyl-CoA desaturase generates unsaturated fatty acids that destabilize ABCA1.

Authors:  Yutong Wang; Buran Kurdi-Haidar; John F Oram
Journal:  J Lipid Res       Date:  2004-02-16       Impact factor: 5.922

9.  Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages.

Authors:  S N Mathur; E Albright; F J Field
Journal:  Biochem J       Date:  1988-12-15       Impact factor: 3.857

10.  Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators.

Authors:  Aksam J Merched; Kerry Ko; Katherine H Gotlinger; Charles N Serhan; Lawrence Chan
Journal:  FASEB J       Date:  2008-06-17       Impact factor: 5.191

View more
  12 in total

1.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

Review 2.  Emerging cellular functions of the lipid metabolizing enzyme 15-Lipoxygenase-1.

Authors:  Melis Çolakoğlu; Sinem Tunçer; Sreeparna Banerjee
Journal:  Cell Prolif       Date:  2018-07-30       Impact factor: 6.831

3.  Silencing carboxylesterase 1 in human THP-1 macrophages perturbs genes regulated by PPARγ/RXR and RAR/RXR: down-regulation of CYP27A1-LXRα signaling.

Authors:  Lee C Mangum; Xiang Hou; Abdolsamad Borazjani; Jung Hwa Lee; Matthew K Ross; J Allen Crow
Journal:  Biochem J       Date:  2018-02-09       Impact factor: 3.857

4.  Nutrigenetic disruption of inflammation-resolution homeostasis and atherogenesis.

Authors:  Aksam J Merched; Charles N Serhan; Lawrence Chan
Journal:  J Nutrigenet Nutrigenomics       Date:  2011-04-07

5.  Murine 12/15-lipoxygenase regulates ATP-binding cassette transporter G1 protein degradation through p38- and JNK2-dependent pathways.

Authors:  Melissa H Nagelin; Suseela Srinivasan; Jerry L Nadler; Catherine C Hedrick
Journal:  J Biol Chem       Date:  2009-08-27       Impact factor: 5.157

6.  15-oxo-Eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation.

Authors:  Cong Wei; Peijuan Zhu; Sumit J Shah; Ian A Blair
Journal:  Mol Pharmacol       Date:  2009-06-17       Impact factor: 4.436

Review 7.  Macrophage cholesteryl ester mobilization and atherosclerosis.

Authors:  Shobha Ghosh; Bin Zhao; Jinghua Bie; Jingmei Song
Journal:  Vascul Pharmacol       Date:  2009-10-28       Impact factor: 5.773

8.  Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein.

Authors:  Susmita Samanta; Kurtis Anderson; Sean Moran; David Hawke; David Gorenstein; Myriam Fornage
Journal:  PLoS One       Date:  2012-08-07       Impact factor: 3.240

9.  Regulation of reverse cholesterol transport - a comprehensive appraisal of available animal studies.

Authors:  Wijtske Annema; Uwe Jf Tietge
Journal:  Nutr Metab (Lond)       Date:  2012-03-29       Impact factor: 4.169

10.  Macrophage PPAR gamma Co-activator-1 alpha participates in repressing foam cell formation and atherosclerosis in response to conjugated linoleic acid.

Authors:  Cathal McCarthy; Nora T Lieggi; Denis Barry; Declan Mooney; Monica de Gaetano; William G James; Sarah McClelland; Mary C Barry; Laure Escoubet-Lozach; Andrew C Li; Christopher K Glass; Desmond J Fitzgerald; Orina Belton
Journal:  EMBO Mol Med       Date:  2013-08-21       Impact factor: 12.137

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.